Search

Search Results

1. Adenosquamous carcinoma of the gallbladder simultaneously producing granulocyte-colony-stimulating factor and parathyroid hormone-related protein

   We report a rare case of adenosquamous carcinoma of the gallbladder which simultaneously produces granulocyte-colony-stimulating factor (G-CSF) and...

   Masahiro Yanagi, Tsuyoshi Suda, ... Eiki Matsushita in Clinical Journal of Gastroenterology

   Article 19 August 2023
   

2. Granulocyte-colony stimulating factor producing cervical cancer with elevated levels of parathyroid hormone-related protein: a case report and literature review

   Systemic effects associated with hormones and cytokines secreted by tumor cells can cause paraneoplastic syndrome. Leukemoid reactions and...

   Naoya Matsuoka, Takayuki Katsuno, ... Yasuhiko Ito in CEN Case Reports

   Article 25 May 2023
   

3. Squamous cell carcinoma of mandibular gingiva producing both parathyroid hormone-related protein and granulocyte colony-stimulating factor: a case report

   We describe a case of mandibular gingival carcinoma with hypercalcaemia and leukocytosis caused by tumour-derived parathyroid hormone-related protein...

   Nobuyuki Kaibuchi, Yuichi Akagi, ... Toshihiro Okamoto in Oral and Maxillofacial Surgery

   Article 29 February 2024
   

4. Vitamin d deficiency with high parathyroid hormone levels is related to late onset SEPSIS among preterm infants

   Summary

   Preterm infants (PTs) are at greater risk for vitamin D deficiency, which relates to the possibility of a higher incidence of comorbidities....

   I. Tofe-Valera, J. L. Pérez-Navero, ... M. J. De la Torre-Aguilar in BMC Pregnancy and Childbirth

   Article Open access 13 January 2023
   

5. Parathyroid diseases and metabolic syndrome

   Purpose

   Parathyroid diseases are related to parathyroid hormone (PTH) dysregulation by parathyroid cells or alteration of PTH function. They include...

   R. Modica, A. Liccardi, ... A. Colao in Journal of Endocrinological Investigation

   Article Open access 11 February 2023
   

6. Potential impacts of SARS-CoV-2 on parathyroid: current advances and trends

   Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection affects several important organs including endocrine glands. Experimental...

   Avaniyapuram Kannan Murugan, Ali S. Alzahrani in Endocrine

   Article 16 June 2023
   

7. Ectopic PTH-producing parathyroid cyst inside the thymus: a case report

   Background

   The hallmark of hyperparathyroidism is hypersecretion of parathyroid hormone (PTH) which results in hypercalcemia and hypophosphatemia....

   Haruka Takenouchi, Takatoshi Anno, ... Hideaki Kaneto in BMC Endocrine Disorders

   Article Open access 21 December 2022
   

8. The significance of an immunohistochemical marker-based panel in assisting the diagnosis of parathyroid carcinoma

   Purpose

   Parathyroid carcinoma (PC) is an endocrine malignancy with a poor prognosis. However, the diagnosis of PC is still a difficult problem. A...

   Ya Hu, Shengwei Mo, ... Quan Liao in Endocrine

   Article Open access 10 February 2024
   

9. Parathyroid carcinoma: molecular therapeutic targets

   Parathyroid carcinoma (PC) is an extremely rare malignant tumor of the parathyroid glands, accounting for less than 1% of primary...

   Francesca Marini, Francesca Giusti, ... Maria Luisa Brandi in Endocrine

   Article 09 May 2023

10. Left parathyroid carcinoma with secondary hyperparathyroidism: a case report

    Background

    Parathyroid carcinoma is a rare disease with a frequency of 0.005% of all malignancies [1, 2]. Various aspects of its pathogenesis,...

    Ko Yokoyama, Nobuyasu Suganuma, Yasushi Rino in BMC Endocrine Disorders

    Article Open access 16 May 2023
    

11. Functional and nonfunctional parathyroid carcinoma: two case reports and literature review

    Parathyroid carcinoma (PC) is a rare malignant endocrine tumor. It can be divided into functional and non-functional types according to the tumor’s...

    Zhidong Yin, ** Xu, ... **aogang Wang in Discover Oncology

    Article Open access 29 November 2023
    

12. Evaluating the association of vitamin D3, parathyroid hormone, and C-reactive protein serum levels in patients with an acute psychotic episode: a cross-sectional study in tertiary centre in Iran

    Background

    The high impact of vitamin D on brain development and its relationship with inflammatory markers in the clinical course of psychiatric...

    Shahrzad Arya, Amirhossein Kamyab, ... Hamid Reza Ahmadkhaniha in BMC Psychiatry

    Article Open access 06 October 2023

13. The effect of intradialytic exercise on calcium, phosphorus and parathyroid hormone: a randomized controlled trial

    Background

    Patients with kidney failure experience derangements of circulating markers of mineral metabolism and dysregulation of skeletal and...

    Mohammad Ali Tabibi, Kenneth R. Wilund, ... Saghar Ahmadi in BMC Nephrology

    Article Open access 20 September 2023
    

14. Down regulation of the inverse relationship between parathyroid hormone and irisin in male vitamin D-sufficient HIV patients

    Purpose

    Infection with the human immunodeficiency virus (HIV) predisposes to endocrine disorders, manifesting as a metabolic phenotype that affects...

    S. N. Karras, T. Koufakis, ... K. Kotsa in Journal of Endocrinological Investigation

    Article 28 May 2023
    

15. The relationship between 18F-FCH uptake intensity and cell content in parathyroid lesions

    Purpose

    To investigate the relationship between cell content and histopathological features of parathyroid lesions and 18F-FCH uptake intensity on...

    Mine Araz, Çiğdem Soydal, ... N. Özlem Küçük in European Archives of Oto-Rhino-Laryngology

    Article 15 February 2023

16. The effect of intermittent parathyroid hormone on bone lengthening: current evidence to inform future effective interventions

    Purpose

    Recent studies have demonstrated the positive effects of parathyroid hormone (PTH) on bone healing, and findings support the use of PTH to...

    Nitchanant Kitcharanant, Nipon Chattipakorn, Siriporn C Chattipakorn in Osteoporosis International

    Article 08 June 2023
    

17. Overview of the 2022 WHO Classification of Parathyroid Tumors

    The 2022 WHO classification reflects increases in the knowledge of the underlying pathogenesis of parathyroid disease. In addition to the classic...

    Lori A. Erickson, Ozgur Mete, ... Anthony J. Gill in Endocrine Pathology

    Article 17 February 2022
    

18. Hyperfunctioning parathyroid gland and skeletal involvement on [¹⁸F]fluorocholine PET/CT: one look with two views

    Hyperparathyroidism is an endocrine disorder that may be associated with other metabolic diseases. Non-invasive imaging techniques including [ ^99m Tc]Tc...

    Carmela Nappi, Leandra Piscopo, ... Alberto Cuocolo in European Journal of Hybrid Imaging

    Article Open access 12 December 2022
    

19. Slow-Reflow and Prognosis in Patients with High Parathyroid Hormone Levels Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction

    We aimed to evaluate the correlation among serum parathyroid hormone (PTH) and slow-reflow during primary percutaneous coronary intervention (PCI)...

    Gangyong Wu, Zufei Wu, ... Gangjun Zong in Journal of Cardiovascular Translational Research

    Article 14 November 2023
    

20. Mortality factors in recurrent parathyroid cancer: a pooled analysis

    Introduction

    Parathyroid cancer is a rare disease with high recurrence rate. The prognostic factors for recurrent parathyroid cancer are yet to be...

    Wen-Hsuan Tsai, Yi-Hong Zeng, ... Ming-Chieh Tsai in Journal of Bone and Mineral Metabolism

    Article 20 February 2022